A detailed history of Miracle Mile Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 4,470 shares of VRTX stock, worth $2.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,470
Previous 2,991 49.45%
Holding current value
$2.1 Million
Previous $1.22 Million 53.49%
% of portfolio
0.05%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$407.69 - $446.08 $602,973 - $659,752
1,479 Added 49.45%
4,470 $1.87 Million
Q4 2023

Jan 22, 2024

BUY
$343.0 - $410.68 $1.03 Million - $1.23 Million
2,991 New
2,991 $1.22 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.